Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples